Cargando…
U.S. racial and ethnic participation in global clinical trials by therapeutic areas
WHAT IS KNOWN AND OBJECTIVE: The discussion about health equity in the United States frequently involves concerns over racial and ethnic minority under‐representation in clinical trials and particularly in trials conducted in support of product approvals. The FDA has long worked to encourage diverse...
Autores principales: | Lolic, Milena, Araojo, Richardae, Okeke, Melvyn, Temple, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290725/ https://www.ncbi.nlm.nih.gov/pubmed/34544200 http://dx.doi.org/10.1111/jcpt.13532 |
Ejemplares similares
-
Racial/Ethnic Disparities in Dietary Intake of U.S. Children Participating in WIC
por: Zimmer, Meghan C., et al.
Publicado: (2019) -
Racial and Ethnic Disparities in U.S. Veteran Health Characteristics
por: Ward, Rachel E., et al.
Publicado: (2021) -
FDA’s Strategies to Close the Health Equity Gap among Diverse Populations
por: Spinner, Jovonni, et al.
Publicado: (2021) -
Differential retention contributes to racial/ethnic disparity in U.S. academia
por: Shaw, Allison K., et al.
Publicado: (2021) -
Developing a Charlson Comorbidity Index for the American Indian Population Using the Epidemiologic Data from the Strong Heart Study
por: Rogers, Paul, et al.
Publicado: (2023)